Literature DB >> 10527842

Selective lysis of virus-infected cells by cobra snake cytotoxins: A sendai virus, human erythrocytes, and cytotoxin model.

G Borkow1, M Ovadia.   

Abstract

By using a Sendai virus-human erythrocyte model, this work found that virus-infected cells were 10-fold more susceptible to lysis in two of five examined cobra venoms. Four cytotoxins were isolated from the venom of the cobra Naja nigricollis that also showed 10-fold higher cytotoxicity toward virus-infected cells than to untreated cells. As selective destruction of virus-infected cells is of immense importance in clinical practice, this work demonstrates the potential of cobra cytotoxins to serve as leading compounds for the generation of derivatives or fractions with high cytotoxic specificity toward virus-infected cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527842     DOI: 10.1006/bbrc.1999.1483

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Cytotoxic potency of cardiotoxin from Naja sputatrix: development of a new cytolytic assay.

Authors:  Donghui Ma; Arunmozhiarasi Armugam; Kandiah Jeyaseelan
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

2.  Phospholipase A2 isolated from the venom of Crotalus durissus terrificus inactivates dengue virus and other enveloped viruses by disrupting the viral envelope.

Authors:  Vanessa Danielle Muller; Ricardo Oliveira Soares; Nilton Nascimento dos Santos; Amanda Cristina Trabuco; Adelia Cristina Cintra; Luiz Tadeu Figueiredo; Antonio Caliri; Suely Vilela Sampaio; Victor Hugo Aquino
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 3.  Antiviral activity of animal venom peptides and related compounds.

Authors:  Élida Cleyse Gomes da Mata; Caroline Barbosa Farias Mourão; Marisa Rangel; Elisabeth Ferroni Schwartz
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-01-06

Review 4.  Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving.

Authors:  Tarek Mohamed Abd El-Aziz; Antonio Garcia Soares; James D Stockand
Journal:  Toxins (Basel)       Date:  2019-09-25       Impact factor: 4.546

Review 5.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

Review 6.  Harnessing the Natural Toxic Metabolites in COVID-19.

Authors:  Ali Bahrami; Mohammad Taheri; Mohammad Reza Arabestani; Meysam Soleimani; Mojdeh Mohammadi; Fatemeh Golabchi; Maryam Banitorfi; Seyed Mostafa Hosseini; Sodabe Khodabandehlou; Fatemeh Nouri
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-07       Impact factor: 2.629

Review 7.  Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?

Authors:  Ahmed S Gouda; Bruno Mégarbane
Journal:  Drug Dev Res       Date:  2020-08-05       Impact factor: 5.004

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.